Literature DB >> 1984093

Endourological experience with cystine calculi and a treatment algorithm.

T A Kachel1, S R Vijan, S P Dretler.   

Abstract

Between May 1984 and January 1988, 18 patients (31 pyeloureteral units) with documented symptomatic cystine stones were treated. Stone size ranged from 5 to 56 mm. in largest diameter, with an average of 21 mm. All pyeloureteral units were treated initially by endourological methods, including ureteroscopy in 10, percutaneous ultrasonic lithotripsy in 9, extracorporeal shock wave lithotripsy (ESWL) in 10 and chemolysis in 2. Of the patients 10 required a combination of these technologies and 2 required an open operation. Of the 31 units 23 were free of stones when the patient was discharged from the hospital. Of 8 patients with retained stones only 3 had fragments greater than 3 mm. in diameter. Based on this experience an algorithm was developed for the urological management of cystine stones. Ureteral calculi may be removed by ureteroscopic techniques or manipulated into the renal pelvis and managed as renal stones. Cystine renal calculi of less than 1.5 cm. may be treated with ESWL monotherapy. Stones of 1.5 to 3 cm. may be treated with ESWL and dissolution, or percutaneous ultrasonic lithotripsy plus dissolution. Staghorn calculi may be treated by percutaneous ultrasonic lithotripsy plus ESWL and/or dissolution for retained fragments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984093     DOI: 10.1016/s0022-5347(17)38237-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Recent advances in lithotripsy technology and treatment strategies: A systematic review update.

Authors:  H E Elmansy; J E Lingeman
Journal:  Int J Surg       Date:  2016-11-24       Impact factor: 6.071

Review 2.  Cystine calculi: challenging group of stones.

Authors:  Kamran Ahmed; Prokar Dasgupta; Mohammad Shamim Khan
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 3.  Management of complex renal calculi.

Authors:  S A Holmes; H N Whitfield
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 4.  Strategies to optimize shock wave lithotripsy outcome: Patient selection and treatment parameters.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  World J Nephrol       Date:  2015-05-06

Review 5.  Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.

Authors:  Thomas Knoll; Antonia Zöllner; Gunnar Wendt-Nordahl; Maurice Stephan Michel; Peter Alken
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

6.  How to improve results with extracorporeal shock wave lithotripsy.

Authors:  Brian R Matlaga; Michelle J Semins
Journal:  Ther Adv Urol       Date:  2009-06

Review 7.  Guidelines for the treatment of acidaemia with THAM.

Authors:  G G Nahas; K M Sutin; C Fermon; S Streat; L Wiklund; S Wahlander; P Yellin; H Brasch; M Kanchuger; L Capan; J Manne; H Helwig; M Gaab; E Pfenninger; T Wetterberg; M Holmdahl; H Turndorf
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

Review 8.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

9.  Extracorporeal shock wave lithotripsy for cystine urolithiasis in children: outcome and complications.

Authors:  Andjelka Slavković; Miladin Radovanović; Zlatko Sirić; Marina Vlajković; Vladisav Stefanović
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

10.  Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy.

Authors:  Samuel C Kim; Erin K Burns; James E Lingeman; Ryan F Paterson; James A McAteer; James C Williams
Journal:  Urol Res       Date:  2007-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.